A major player in systemic low-grade chronic inflammation in obesity is the increased numbers of adipose tissue pro-inflammatory MΦs and deregulated production and function of adipose tissue hormones and adipokines including adiponectin [105], which strongly contributes to the initiation and exacerbation of type 2 diabetes [106]. Here, ADIPOQ is linked to obesity disorder.